A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: engaged (185), occupied (51), unavailable (47)

Testing for gene variants in inherited breast, ovarian and prostate cancers - patient information

Description
Information about testing for gene variants in inherited breast, ovarian and prostate cancers.
Url
/Media/UHS-website-2019/Patientinformation/Genetics/Testing-for-gene-variants-in-inherited-breast-ovarian-and-prostate-cancers-1980-PIL.pdf

Remuneration and Appointment Committee ToR May 2022

Description
Remuneration and Appointment Committee Terms of Reference Date Issued: 26 May 2022 Review Date: November 2022 Document Typ
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2022-Trust-documents/Remuneration-and-Appointment-Committee-ToR-May-2022.pdf

After evacuation of a chronic subdural haematoma - patient information

Description
This factsheet contains useful information and advice after evacuation of a chronic subdural haematoma.
Url
/Media/UHS-website-2019/Patientinformation/Brain-and-spine/After-evacuation-of-a-chronic-subdural-haematoma-1987-PIL.pdf

AMS FLIER summary 2022 - cohort 3 applications open

Description
Future Leaders in Innovation, Enterprise and Research (FLIER) Programme The Academy of Medical Sciences is pioneering a unique programme to develop
Url
/Media/Southampton-Clinical-Research/Grants/AMS-FLIER-summary-2022-cohort-3-applications-open.pdf

Gemcitabine

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) GEMCITABINE Regimen NSCLC - Gemcitabine Indication Second line therapy
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Gemcitabinever12.pdf

Gemcitabine RT ver1

Description
Chemotherapy Protocol BLADDER CANCER GEMCITABINE RT Regimen Bladder – Gemcitabine RT Indication The treatment of muscle invasive bl
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Gemcitabine-RT-ver1.pdf

Gemcitabine (21day) ver1.1

Description
Chemotherapy Protocol BLADDER GEMCITABINE (21 day) Regimen Bladder-Gemcitabine Indication Locally advanced or metastatic urothelial
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Gemcitabine-21day-ver1.1.pdf

Fluorouracil Mitomycin RT

Description
Chemotherapy Protocol BLADDER CANCER FLUOROURACIL-MITOMYCIN-RADIOTHERAPY Regimen • Bladder Cancer – Fluorouracil-Mitomycin-Radioth
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Fluorouracil-Mitomycin-RT.pdf

Vinorelbine (intravenous)

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) VINORELBINE (Intravenous) Regimen NSCLC - Vinorelbine (Intravenous) Ind
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Vinorelbineintravenousver12.pdf

Atezolizumab1680mg

Description
Chemotherapy Protocol LUNG CANCER Atezolizumab (1680mg 28 days) Regimen • Lung – Atezolizumab Indication • Atezolizumab is indicate
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Atezolizumab1680mg.pdf
761 to 770 of 1000
Previous … 75 76 77 78 79 … Next